Cancer nanomedicine toward clinical translation: Obstacles, opportunities, and future prospects
Pengfei Zhang(Louisiana State University), Wei Tao(Nanjing Forestry University), Alexey V. Yaremenko(Brigham and Women's Hospital), Yufen Xiao(The University of Texas Southwestern Medical Center), Omid C. Farokhzad(Brigham and Women's Hospital), Seyoung Koo(Hanyang University), Na Kong(Brigham and Women's Hospital), Duotian Qin(Brigham and Women's Hospital), Xue Sun(Zhongshan Hospital of Xiamen University), Xiaoning Lin(Northeast Normal University)
Cited by 222
Related Papers
Cancer nanomedicine: progress, challenges and opportunities
|Nature reviews. Cancer|2016|5.6k
Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology
|Cancer Research|2013|1.5k
Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics
|Nature Communications|2017|679
Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis
|Nature Reviews Cardiology|2021|487
The landscape of mRNA nanomedicine
|Nature Medicine|2022|471